Abstract: Compositions comprising a high amount of a liquid oil, a lactylate, and at least one of an alkanolamide and a sarcosinate are disclosed. The high oil content effectively removes oily residues from a surface treated with the composition. The compositions are essentially free of water, but are water rinsable to effect easy and rapid removal of the composition from a surface.

Abstract: A cleaner/polish composition for application to a hard surface, followed by wiping, to provide a clean, shiny surface is disclosed. The composition contains a functionalized dimethicone, nonionic surfactants, emulsifiers, a silicone fluid, an oxidized wax, an alkamidoalkyl dialkylamine, and water.

Abstract: Surfactant blends that generate a stable spherical foam are disclosed. The surfactant blends contain a nonionic surfactant or an amphoteric surfactant as the principal foaming agent, and a sufficient amount of an acylate lactylate to enhance foam volume and provide a foam that remains in a spherical form for up to about forty minutes. A method of generating a long-lasting foam also is disclosed.

Abstract: Balanced emulsifier blends that provide a stable oil-in-water emulsion of preselected viscosity are disclosed. The emulsifier blend contains an acyl lactylate as the primary emulsifier and a nonionic surfactant as the coemulsifier. A method of preparing an oil-in-water emulsion having a preselected viscosity also is disclosed.

Abstract: A cosmetic component is produced by dispersing in water a water-soluble fiber composed of about 4 to 6 weight percent beta glucan, about 1 to 5 weight percent fat, about 80 to 94 weight percent carbohydrates and less than 8 weight percent protein. The fiber composition forms a dispersion (e.g., a first paste or gel) with the hot water, which is mixed for about 1 to 5 minutes. Following mixing, the dispersion is cooled and then combined with one or more stable cosmetic components to form a cosmetic product. One novel cosmetic component useful with the invention is composed of: (a) about 4.0 to about 8.0 percent water by weight; (b) about 4.5 to about 5.5 percent beta-glucan by weight; (c) less than 8.0 percent protein by weight; (d) about 2.0 to 3.0 percent ash by weight; (e) about 1.0 to about 5.0 percent fat by weight; and (f) about 80 to about 94 percent carbohydrate by weight.

Abstract: A cosmetic component is produced by dispersing in water a water-soluble fiber composed of about 4 to 6 weight percent beta glucan, about 1 to 5 weight percent fat, about 80 to 94 weight percent carbohydrates and less than 8 weight percent protein. The fiber composition forms a dispersion (e.g., a first paste or gel) with the hot water, which is mixed for about 1 to 5 minutes. Following mixing, the paste is cooled and then combined with one or more stable cosmetic components to form a cosmetic product. One novel cosmetic component useful with the invention is composed of: (a) about 4.0 to about 8.0 percent water by weight; (b) about 4.5 to about 5.5 percent beta-glucan by weight; (c) less than 8.0 percent protein by weight; (d) about 2.0 to 3.0 percent ash by weight; (e) about 1.0 to about 5.0 percent fat by weight; and (f) about 80 to about 94 percent carbohydrate by weight.

Abstract: Cosmetic Base composition exhibiting therapeutic properties comprising an acyl fatty acid alpha-hydroxy carboxylic acid ester or alkali metal salt thereof, a sucrose fatty acid ester, and a solvent.

Abstract: This invention relates to a foldable roadmarker of the type comprising a vertical rectangular panel presenting colored bands and a foldable support composed of four feet articulated in two's to form two pairs of compasses located on either side of the panel and the two pairs of compasses are articulated on the same transverse rod which projects on both sides and which slides freely in two slots cut out in the vertical edges of the panel, which rod is adapted to engage in two slideways of a container for storing the roadmarkers.

Abstract: Cosmetic Base composition exhibiting therapeutic properties includes an acyl fatty acid lactylate ester or alkali metal salt thereof, a sucrose fatty acid ester, and a solvent.

Abstract: Appliance for the treatment, particularly in a liquid, of a product like leather, consisting of a perforated drum (1) containing compartments (9, 10, 11) separated by partitions (12, 13, 14) and connecting with the outside via openings (9a, 9b, 9c) closed by doors, along with a tank (7) surrounding the drum (1) and provided with an opening (8), a fixing means enabling the drum (1) and the tank (7) to be fixed together in rotation when the opening (9a) of a compartment (9) is placed opposite the opening (8) in the tank (7) and a drive means (22) enabling the drum (1) and the tank (7) to be swung round jointly between a first position in which the opening (8) of the tank is in a top position and a second position in which the opening (8) of the tank is placed on the side, the said first position corresponding to the treatment and loading of the product and the second position corresponding to its discharge.

Abstract: Non-pathogenic varicella-zoster virus mutants are obtained by induction and isolation of temperature-sensitive mutant strains. N-methyl-N'-nitro-N-nitrosoguanidine is employed as mutagenic agent. The obtained mutants are useful for vaccine production.

Abstract: Penicillin derivative substituted at the 6 position with a (D)-[(2-amino-2-carboxy)-ethylthio]-acetamido group is obtained from Acremonium Chrysogenum new strain ATCC 20 389 or by semi-synthetic route. The product is an antibacterial agent.

Abstract: Cephalosporin compounds with 3-substituted ureido or -thioureido group at position 7 and hydrogen or heterocyclicthiomethyl groups at position 3 are prepared. These compounds are antibacterial agents.

Abstract: Cephalosporin compounds with 3-substituted ureido or -thioureido group at position 7 and hydrogen or heterocyclicthiomethyl groups at position 3 are prepared. These compounds are antibacterial agents.

Abstract: The invention relates to live virus vaccines containing temperature-sensitive mutant strains of bovine Adenovirus, the cut-off temperature of said mutant strain being comprised between 39.degree. and 40.degree. C.The invention also relates to the induction of said temperature-sensitive mutant strains and to a vaccination method by intranasal administration of the obtained vaccines.

Abstract: Attenuated stable influenza type B virus strains are obtained by recombining a vaccinal and previously attenuated influenza type B virus strain with an influenza type B virus isolate having the desired serotype and isolating a recombinant having at least one marker property of the attenuated parent strain which is not shared by the other parent strain and the antigenic composition of the other parent strain. The obtained strains are useful for the production of nasal influenza vaccines.

Abstract: Stable H.sub.3 N.sub.2 influenza virus strains completely resistant to serum inhibitors are obtained by passaging at least one time in the allantoic cavity of embryonated eggs in the presence of serum a recombinant strain previously obtained from an H.sub.3 N.sub.2 influenza strain and the A/PR.sub.8 influenza virus strain and isolating the so-obtained serum inhibitors resistant strains. The obtained strains are useful for vaccine production.

Abstract: The invention relates to the stereoisomers of novel cyclopentene derivatives and to the preparation thereof.The cyclopentene derivatives are obtained by cycloaddition reaction between cyclopentadiene and a mono-or bis-thioalkyl (or aryl) ketene and reaction between the obtained product and a nucleophile agent.The compounds of the invention are intermediate products valuable for the preparation of different compounds, among which compounds of the prostaglandin type.